Screening and Care for Fear of Cancer Recurrence in Patients With Cancer at Institut Curie

Recruiting now

Conditions studied: Lung Cancer, Breast Cancer

In brief

The goals of this study is to establish the prevalence of severe forms of FCR in the oncology hospital setting, which will require a specific psychotherapeutic response. Two cancer sites are targeted: breast and pulmonary cancers. Secondary objectives include: 1) Determining threshold scores for the FCRI's 9-item severity scale for each type of cancer; 3) To identify a simple item from the FCRI for early detection of FCR in everyday clinical practice, especially using a digital format.

Key facts

Study ID

NCT07357311

Run by

Institut Curie

People needed

200

Starts

2025-09-08

Expected to finish

2027-12-31

Last updated by the study team

2026-01-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged 18 or over
• Clinical or pathological diagnosis of primary or recurrence of a localized/loco-regional or metastatic breast cancer, or a stage 1 or 2, or stage 3 or 4 lung cancer; or a breast or lung cancer metastatic progression
• Three months after completing treatment or three months after the start of a first treatment line for metastatic progression
• Able to comply with the scheduled assessment and interviews
• Able to read and understand the questionnaires' language (i.e. French)

You may not qualify if…

• Participating in another patient-reported outcome study interfering with the present study
• Any social, medical or psychological condition hindering questionnaire completion
• Being deprived of personal liberty or under guardianship

Where it is running

• Institut Curie — Paris, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.